Germany - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingGermany: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Germany
The German market for hormones, prostaglandins, thromboxanes and leukotrienes soared to $X in 2021, growing by 21% against the previous year. Overall, consumption posted a prominent expansion. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked in 2021 and is likely to continue growth in the immediate term.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Germany
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production reduced slightly to $X in 2021 estimated in export price. Over the period under review, production, however, recorded a perceptible shrinkage. The growth pace was the most rapid in 2013 with an increase of 41% against the previous year. Hormones, prostaglandins, thromboxanes and leukotrienes production peaked at $X in 2014; however, from 2015 to 2021, production remained at a lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from Germany
Hormones, prostaglandins, thromboxanes and leukotrienes exports from Germany dropped sharply to X tons in 2021, waning by -29.5% on the previous year's figure. In general, exports continue to indicate a abrupt decline. The pace of growth appeared the most rapid in 2014 when exports increased by 23%. As a result, the exports attained the peak of X tons. From 2015 to 2021, the growth of the exports remained at a lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports fell notably to $X in 2021. Over the period under review, total exports indicated a notable increase from 2012 to 2021: its value increased at an average annual rate of +3.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 with an increase of 47% against the previous year. As a result, the exports attained the peak of $X. From 2015 to 2021, the growth of the exports remained at a lower figure.
Exports by Country
Mexico (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Germany, accounting for a 35% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Mexico exceeded the volume sent to the second major destination, France (X tons), twofold. The third position in this ranking was taken by the United States (X tons), with an 8.8% share.
From 2012 to 2021, the average annual growth rate of volume to Mexico totaled -3.9%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (-21.2% per year) and the United States (+15.6% per year).
In value terms, the United States ($X) remains the key foreign market for hormones, prostaglandins, thromboxanes and leukotrienes exports from Germany, comprising 37% of total exports. The second position in the ranking was held by Italy ($X), with a 5.4% share of total exports. It was followed by Mexico, with a 3.6% share.
From 2012 to 2021, the average annual rate of growth in terms of value to the United States stood at +34.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (+6.7% per year) and Mexico (-2.2% per year).
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, surging by 14% against the previous year. Over the period under review, the export price showed a resilient increase. The most prominent rate of growth was recorded in 2017 when the average export price increased by 57% against the previous year. Over the period under review, the average export prices attained the maximum in 2021 and is likely to continue growth in the near future.
There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was the United States ($X per kg), while the average price for exports to France ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+16.0%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into Germany
In 2021, approx. X tons of hormones, prostaglandins, thromboxanes and leukotrienes were imported into Germany; with an increase of 16% compared with the previous year. Over the period under review, total imports indicated measured growth from 2012 to 2021: its volume increased at an average annual rate of +2.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +102.4% against 2015 indices. The most prominent rate of growth was recorded in 2018 with an increase of 23% against the previous year. Over the period under review, imports reached the peak figure in 2021 and are likely to see steady growth in the immediate term.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports surged to $X in 2021. Overall, imports, however, saw a pronounced downturn. Over the period under review, imports reached the maximum at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.
Imports by Country
Mexico (X tons), China (X tons) and Ireland (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to Germany, together comprising 65% of total imports.
From 2012 to 2021, the biggest increases were recorded for Ireland (with a CAGR of +100.6%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, Ireland ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to Germany, comprising 32% of total imports. The second position in the ranking was taken by Argentina ($X), with a 12% share of total imports. It was followed by Belgium, with a 12% share.
From 2012 to 2021, the average annual growth rate of value from Ireland amounted to +50.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Argentina (+10.1% per year) and Belgium (+19.5% per year).
Import Prices by Country
The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, rising by 23% against the previous year. In general, the import price, however, saw a abrupt decline. The growth pace was the most rapid in 2014 when the average import price increased by 24%. As a result, import price reached the peak level of $X per kg. From 2015 to 2021, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the Netherlands ($X per kg), while the price for Mexico ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by France (+10.2%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Germany. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- Germany
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Germany
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.